Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: August 20, 2017
What are the generic sources for cefazolin sodium and what is the scope of cefazolin sodium patent protection?
Cefazolin sodium is the generic ingredient in eight branded drugs marketed by Baxter Hlthcare, Acs Dobfar, Facta Farma, West-ward Pharms Int, Steri Pharma, Teva Pharms, Hospira Inc, Sandoz, Baxter Hlthcare Corp, Glaxosmithkline, Samson Medcl, Hikma Farmaceutica, Lilly, Qilu Pharm Co Ltd, Fresenius Kabi Usa, B Braun, Cephazone Pharma, Abraxis Pharm, Watson Labs Inc, Bedford, and Aurobindo Pharma, and is included in thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.| Tradenames: | 8 |
| Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 38 |
| Drug Master File Entries: see list | 27 |
| Suppliers / Packagers: see list | 19 |
| Bulk Api Vendors: see list | 51 |
| Clinical Trials: see list | 2,448 |
| Patent Applications: see list | 2,280 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | cefazolin sodium at DailyMed |
| Ingredient-type | Cephalosporins |
| Drug Class | Cephalosporin Antibacterial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-003 | Jan 13, 2012 | RX | Yes | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Glaxosmithkline | ANCEF | cefazolin sodium | INJECTABLE;INJECTION | 050461-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Sandoz | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 062831-001 | Dec 9, 1988 | AP | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
West-ward Pharms Int | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 062807-005 | Jan 12, 1988 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Watson Labs Inc | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 062989-002 | Dec 29, 1989 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,363 others who get our Drug Patent Expiration Alerts:
